| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. | N Engl J Med | 2009 | 5.79 |
| 2 | Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity. | Clin Cancer Res | 2008 | 1.66 |